Cardiovascular disease in kidney donors: matched cohort study
- PMID: 22381674
- PMCID: PMC3291749
- DOI: 10.1136/bmj.e1203
Cardiovascular disease in kidney donors: matched cohort study
Abstract
Objective: To determine whether people who donate a kidney have an increased risk of cardiovascular disease.
Design: Retrospective population based matched cohort study.
Participants: All people who were carefully selected to become a living kidney donor in the province of Ontario, Canada, between 1992 and 2009. The information in donor charts was manually reviewed and linked to provincial healthcare databases. Matched non-donors were selected from the healthiest segment of the general population. A total of 2028 donors and 20,280 matched non-donors were followed for a median of 6.5 years (maximum 17.7 years). Median age was 43 at the time of donation (interquartile range 34-50) and 50 at the time of follow-up (42-58).
Main outcome measures: The primary outcome was a composite of time to death or first major cardiovascular event. The secondary outcome was time to first major cardiovascular event censored for death.
Results: The risk of the primary outcome of death and major cardiovascular events was lower in donors than in non-donors (2.8 v 4.1 events per 1000 person years; hazard ratio 0.66, 95% confidence interval 0.48 to 0.90). The risk of major cardiovascular events censored for death was no different in donors than in non-donors (1.7 v 2.0 events per 1000 person years; 0.85, 0.57 to 1.27). Results were similar in all sensitivity analyses. Older age and lower income were associated with a higher risk of death and major cardiovascular events in both donors and non-donors when each group was analysed separately.
Conclusions: The risk of major cardiovascular events in donors is no higher in the first decade after kidney donation compared with a similarly healthy segment of the general population. While we will continue to follow people in this study, these interim results add to the evidence base supporting the safety of the practice among carefully selected donors.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Comment in
-
Does reduced glomerular filtration rate equate to chronic kidney disease?BMJ. 2012 Mar 1;344:e1167. doi: 10.1136/bmj.e1167. BMJ. 2012. PMID: 22381673 No abstract available.
-
Kidney donation does not increase cardiovascular risk.Nat Rev Nephrol. 2012 Mar 20;8(5):253. doi: 10.1038/nrneph.2012.50. Nat Rev Nephrol. 2012. PMID: 22430057 No abstract available.
-
Invite all donors to participate in follow-up studies.BMJ. 2012 Apr 18;344:e2724. doi: 10.1136/bmj.e2724. BMJ. 2012. PMID: 22514221 No abstract available.
-
Living donor registries are needed.BMJ. 2012 Apr 18;344:e2727. doi: 10.1136/bmj.e2727. BMJ. 2012. PMID: 22514223 No abstract available.
-
Selection of controls in kidney donor outcome studies: an admirable effort.Am J Kidney Dis. 2013 Feb;61(2):194-6. doi: 10.1053/j.ajkd.2012.07.013. Epub 2012 Aug 21. Am J Kidney Dis. 2013. PMID: 22917667 No abstract available.
Similar articles
-
Acute dialysis risk in living kidney donors.Nephrol Dial Transplant. 2012 Aug;27(8):3291-5. doi: 10.1093/ndt/gfr802. Epub 2012 Jan 30. Nephrol Dial Transplant. 2012. PMID: 22290988 Free PMC article.
-
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.Transplantation. 2008 Aug 15;86(3):399-406. doi: 10.1097/TP.0b013e31817ba9e3. Transplantation. 2008. PMID: 18698242
-
Gout after living kidney donation: a matched cohort study.Am J Kidney Dis. 2015 Jun;65(6):925-32. doi: 10.1053/j.ajkd.2015.01.017. Epub 2015 Mar 25. Am J Kidney Dis. 2015. PMID: 25818677
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
Risk for cancer in living kidney donors and recipients.J Cancer Res Clin Oncol. 2018 Mar;144(3):543-550. doi: 10.1007/s00432-018-2590-z. Epub 2018 Jan 22. J Cancer Res Clin Oncol. 2018. PMID: 29356887 Review.
Cited by
-
Pros and cons of live kidney donation in prediabetics: A critical review and way forward.World J Transplant. 2024 Mar 18;14(1):89822. doi: 10.5500/wjt.v14.i1.89822. World J Transplant. 2024. PMID: 38576756 Free PMC article. Review.
-
Long-term Medical Outcomes of Living Kidney Donors.Mayo Clin Proc. 2022 Nov;97(11):2107-2122. doi: 10.1016/j.mayocp.2022.06.013. Epub 2022 Oct 7. Mayo Clin Proc. 2022. PMID: 36216599 Free PMC article. Review.
-
Long-term renal and cardiovascular outcome of living kidney donors: A single-center retrospective observation study.Front Med (Lausanne). 2022 Sep 14;9:966038. doi: 10.3389/fmed.2022.966038. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36186783 Free PMC article.
-
Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance.Am J Transplant. 2022 Oct;22(10):2360-2380. doi: 10.1111/ajt.17122. Epub 2022 Aug 3. Am J Transplant. 2022. PMID: 35716049 Free PMC article.
-
Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?Clin Kidney J. 2021 Dec 13;15(4):644-656. doi: 10.1093/ckj/sfab271. eCollection 2022 Apr. Clin Kidney J. 2021. PMID: 35371443 Free PMC article. Review.
References
-
- Horvat LD, Shariff SZ, Garg AX. Global trends in the rates of living kidney donation. Kidney Int 2009;75:1088-98. - PubMed
-
- Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006;145:185-96. - PubMed
-
- Young A, Nevis IF, Geddes C, Gill J, Boudville N, Storsley L, et al. Do biochemical measures change in living kidney donors? A systematic review. Nephron Clin Pract 2007;107:c82-9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical